Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole

MLA

Edith A. Perez, et al. “Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole.” The Oncologist, vol. 13, no. 5, June 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35f8b43d612c222f23e96cb98059a2a0&authtype=sso&custid=ns315887.

APA

Edith A. Perez, Robert E. Coleman, N. Schenk, Raul Mena, Solveig G. Ericson, Nigel J Bundred, Lixian Jin, Rosemary Lambert-Falls, Adam Brufsky, & Peyman Hadji. (2008). Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole. The Oncologist, 13(5).

Chicago

Edith A. Perez, Robert E. Coleman, N. Schenk, Raul Mena, Solveig G. Ericson, Nigel J Bundred, Lixian Jin, Rosemary Lambert-Falls, Adam Brufsky, and Peyman Hadji. 2008. “Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole.” The Oncologist 13 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35f8b43d612c222f23e96cb98059a2a0&authtype=sso&custid=ns315887.